Navigation Links
Quebec Clinic Launches Canadian Use of Elekta's Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
Date:12/6/2012

LAVAL, Canada, Dec. 6, 2012 /PRNewswire/ – Two female patients 53 and 86 years old, became the first in Canada to receive radiation therapy on a treatment system equipped with Elekta's revolutionary Agility™* 160 leaf multi-leaf collimator (MLC), which rapidly and accurately shapes the beams used in radiation therapy. Clinicians administered the treatments on November 26 at Centre integre de cancerologie de Laval (CICL), located on the North Shore of Montreal. Elekta recently received clearance from Health Canada to sell Agility within the Canadian health care system.

"CICL is a new cancer facility that began treating patients in February 2012," says CICL's Head of Physics Fadi Hobeila. "Since our mission is clinical excellence, we wanted to have the best technology possible on our two Elekta Synergy® treatment machines, which meant upgrading them with Agility."

With double the leaf speed of other MLCs used in concert with Elekta's Continuously Variable Dose Rate (CVDR) – Agility, with the Integrity™ digital control system, has enabled CICL physicians to fully exploit Volumetric Modulated Arc Therapy (VMAT), a fast arc technique that significantly accelerates treatments.

"One of the patients we treated today (Nov. 26) employed a two-arc VMAT plan, which took just 1.5 minutes per arc," reports Marie-Andree Fortin, M.D., Head of Radiation Oncology at Centre de sante et de services sociaux (CSSS) de Laval, CICL's parent organization. "Before Agility, we wouldn't have treated that patient with VMAT, because the plan quality would not be equivalent. We would have used standard step-and-shoot IMRT, which would have taken 12 to 15 minutes to deliver the beams."

CICL uses VMAT in 25 percent of its caseload, she adds.

Other Agility features – narrow 5 mm leaves, extremely low transmission and high positional accura
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
2. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
3. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
4. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
5. RxAlly Adds Accomplished Clinical Services Expert And Pharmacist, Rebecca Chater, To The Companys Leadership Team
6. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
7. Elseviers Clinical Pharmacology Now Accessible Through Elsevier Infobutton
8. ClinicalKey Key Innovator Award to Recognize the Innovative Use of Health Information and Technology to Save and Improve Lives
9. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
10. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
11. Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- CVS Caremark Corporation (NYSE: CVS ) announced ... payable in connection with its previously announced cash tender offers ... any and all of its 6.250% Senior Notes due 2027 ... maximum amount of its 6.125% Senior Notes due 2039, 5.750% ... (collectively, the "Maximum Tender Offer Notes" and together with the ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis ... three independent members to its Board of Directors, ... experience of the company, a leading licensed producer ... . Internationally, Bedrocan has 13 years, experience in ... in seven countries, including Canada. ...
(Date:8/21/2014)... 2014  SI-BONE, Inc. ( San Jose, California ... use of the iFuse Implant System, ® a ... the sacroiliac (SI) joint, announced that Priority Health ( ... Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage ... states that the fusion procedure, which employs the iFuse ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... 29, 2011  Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... in 2012 through the development and sales of its ... management of medical conditions. In 2011, Solos Endoscopy consummated ... in debt for the Company. The signed settlement agreement ...
... Today, Zacks Equity Research discusses the Pharma & Biotech, ... Human Genome Sciences Inc. (Nasdaq: HGSI ... and Perrigo Company (Nasdaq: PRGO ). ... synopsis of today,s Industry Outlook is presented below. The ...
Cached Medicine Technology:Solos Endoscopy, Inc. is Primed for Growth in 2012 2Solos Endoscopy, Inc. is Primed for Growth in 2012 3Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo 2Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo 3Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo 4
(Date:8/22/2014)... Teen substance abuse has long been major issue ... adults never receive the professional treatment they need. To ... Troubled Teens Columbus helpline was established to provide a ... and alcohol dependencies . , By calling ... can speak directly to a representative who can offer ...
(Date:8/22/2014)... 22, 2014 Drug and alcohol ... the years, substance abuse has claimed thousands of lives ... OH is providing hope for teenagers who are seeking ... helpline is designed to provide adolescents and their parents ... find the best youth rehab facility to meet their ...
(Date:8/22/2014)... Dr Murray Grossan was interviewed for an ... In the October 2014 issue of Bottom Line Personal magazine, ... method of treating snoring, and in some cases Obstructive Sleep ... of all adults snore occasionally, and about 25% do it ... passages in the back of the throat tend to sag ...
(Date:8/22/2014)... August 22, 2014 According to ... System and Adaptive Cruise Control (ACC) System Market ... Forecasts 2014 - 2019", published by MarketsandMarkets, classifies ... Market in terms of volume and value. The ... years as well as covers review of the ...
(Date:8/21/2014)... Dallas, TX (PRWEB) August 22, 2014 ... proportion of reimbursement for medical expenses, the Chinese ... with its scale presenting a CAGR of 19.2% ... products are three product segments of orthopedic instruments ... bulk with 36.9% market share in 2013. , ...
Breaking Medicine News(10 mins):Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4
... the star had a miscarriage in 2005 . ,Pregnancy ... they tied the knot in September 2005, and now Lesley Guynes ... in fact become pregnant, but she lost the baby. ... her own. Demi and Ashton have been trying (to have a ...
... rights group PETA has commended Sir Paul McCartney for his ... ,The former Beatle, who has supported cancer charities ... 1998, recently revealed that he is planning to decline financial ... that he took the decision after discovering that a number ...
... have confirmed a long-standing belief that male circumcision can ... an international AIDS conference will be told next week ... International AIDS Society (IAS) conference to be held in ... represented a major development in HIV prevention. ...
... alarming depletion of ground water levels in the country and ... water table. ,The Central Groundwater Board has ... level at various places across the country and identified about ... score, a senior official said. ,"The constant mining ...
... left-handers, natural lefties who have switched over to right hand ... their brains are organized, and how hard particular regions ... in such peoples brains continue to retain characteristics of a ... righty. ,"The question now is, 'do converts suffer ...
... Novartis AG has been given the green light from the European ... still no access to its American counterpart. ... European Medicines Agency came soon after Novartis said it would ... due to a request for more safety data. ...
Cached Medicine News:Health News:Male Circumcision can Cut HIV Infection, Studies Show 2Health News:Groundwater Levels Depleting Alarmingly in India 2Health News:Converting Left-hander to Right-hander also Changes the Brain 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: